- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Metabomed Ltd.
Headquarters: Yavne, Israel
Website: N/A
Year Founded: 2013
Status: Out of Business
BioCentury | Sep 27, 2023
Discovery & Translation
Targeting ACSS2 in solid tumors; plus a multi-lab preclinical trial and more
BioCentury’s roundup of translational innovation
BioCentury | Apr 24, 2020
Emerging Company Profile
FoRx: A broader look at DNA damage repair
FoRx is using synthetic lethality to attack a broad set of cancers with new DNA damage repair targets
BioCentury | Jun 22, 2017
Emerging Company Profile
Repare in progress
Synthetic lethality play Repare emerges from stealth with $68M series A
BioCentury | Mar 31, 2017
Finance
It takes two
Tango joins synthetic lethality crowd with $55M series A from Third Rock
Items per page:
1 - 8 of 8